Which TSX Stock is Best to Buy Today?

A fast-rising growth stock in the healthcare sector is the best TSX stock you can buy today.

| More on:

The Toronto Stock Exchange has been resilient for most of 2024, although it has been mirroring the movement of Wall Street across the border lately. Canada’s primary stock market has been on a rollercoaster ride since the start of August. The year-to-date gain has narrowed to 4.4%, with three of 11 primary sectors in the red.

Many individual stocks continue to outperform and beat the market. Celestica (TSX:CLS) benefits from the artificial intelligence boom and is up 57.5% year-to-date, a close second to American AI king NVIDIA.

However, if you’re looking for the best TSX stock to buy today, one name stands out in the healthcare sector. Small-cap stock Vitalhub Corp. (TSX:VHI) has soared, notwithstanding the elevated market volatility. At only $8.21 per share, current investors enjoy a 101.2% year-to-date gain.

Vitalhub’s trailing-one-year price return is 229.7% and had you invested $6,498.90 a year ago ($2.49 per share), your money would be $21,428.10 today. VHI is fast-rising and has the makings of a high-growth stocks. Also, market analysts covering the stock recommend a ‘strong buy’ rating because the business is growing.

Health Information Services

The $416.6 million company from Toronto operates in the Health Information Services industry and develops healthcare software. Vitalhub caters to health and human services providers as well as stakeholders such as regional health authorities, and hospitals, among others.

VitalHub offers comprehensive Software-as-a-Service (SaaS) solutions, including Electronic Health Record, patient flow, and workforce automation and compliance.

Partnerships and acquisitions

Establishing partnerships to widen reach and coverage is an ongoing concern. The latest is with Lumenus Community Services, an organization that provides comprehensive support services for individuals and families. Management is likewise pursuing strategic acquisitions to strengthen Vitalhub’s market position.

In June this year, Vitalhub acquired Premier I.T. Partnership Limited, a company offering workforce planning, development, and performance solutions for the healthcare sector. The acquisition will help strengthen relationships with all combined healthcare customers in the United Kingdom.

Late last month, Vitalhub signed a definitive agreement to acquire MedCurrent Corporation and its subsidiaries, an arrangement approved by the court under the Business Corporations Act.

MedCurrent is a Clinical Decision Support (CDS) company focused on improving the quality of care and managing health system costs. The closing of the MedCurrent transaction will increase Vitalhub’s operating companies to 10.

Financial performance

In Q1 2024, Vitalhub’s revenue increased 17.5% to $15.2 million versus Q1 2023, while net income jumped 87.7% year-over-year to $1.3 million. Its CEO, Dan Matlow, said, “We are thrilled to report that VitalHub has kicked off 2024 with outstanding momentum.” He adds that the focus is on driving operational excellence and continuous expansion of solution offerings.

Other significant business highlights are the 56% year-over-year increase in EBITDA (earnings before interest, taxes, depreciation, and amortization) to $3.1 million and the 31% jump of the annual recurring revenue (ARR) to $47.8 million from a year ago.

Unstoppable growth trajectory

Matlow said confidently, “As we move through 2024, VitalHub is well-positioned to continue our growth trajectory.” The growth is well-planned: expanding reach in existing markets, exploring new opportunities, and enhancing the product portfolio through innovation and strategic mergers and acquisitions. Expect the stock to deliver outsized gains in 2024 and beyond if plans are met.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vitalhub. The Motley Fool has a disclosure policy.

More on Tech Stocks

bulb idea thinking
Tech Stocks

The Smartest Canadian Stock to Buy With $1,000 Right Now

Strong financials, booming demand for its services, and an expanding presence in AI and cloud computing hardware make Celestica the…

Read more »

doctor uses telehealth
Tech Stocks

3 Tech Stocks I’m Looking to Buy in February

These tech stocks will deliver solid gains driven by the deployment of AI and investments in omnichannel commerce and digital…

Read more »

Burning semiconductor CPU
Tech Stocks

Is AMD in Trouble After Wednesday’s Stock Drop?

Shares took a painful hit after the chip designer's fourth-quarter report.

Read more »

An investor uses a tablet
Tech Stocks

If I Could Only Buy and Hold a Single Stock, This Would Be it

Despite more than doubling in value over the last six months, I still find BlackBerry stock undervalued based on its…

Read more »

chip with the letters "AI" on it
Tech Stocks

Celestica Stock Trading at All-Time High: What’s Next?

Celestica stock is beating Nvidia, surging 1,358% since October 2022. Today, it is trading at its all-time high. Is there…

Read more »

dividend growth for passive income
Tech Stocks

2 Growth Stocks That Could Turn $10,000 Into $24,800 by 2030

These resilient growth stocks could grow your money.

Read more »

Credit card, online shopping, retail
Tech Stocks

Where Will Shopify Shares Be in 5 Years?

In addition to Shopify’s consistently growing sales and expanding profit margins, its focus on long-term growth initiatives could help its…

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »